tiprankstipranks
Trending News
More News >
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558)
:1558
Hong Kong Market

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (1558) Revenue

Compare
0 Followers

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H Revenue

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H had a revenue of 1.27B in the quarter ending Dec 31, 2024, with -48.30%. This bring the company's revenue in the last twelve months to 3.72B, Increased -32.79%. In the fiscal year ending Dec 31, 2024, YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H had annual revenue of 3.72B with -40.84% growth.
Revenue (ttm)
3.72B
Revenue Growth
-42.02%
P/S Ratio
3.40
Revenue/Employee
HK$766,053
Employees
4,861
Market Cap
HK$12.65B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
3.72B-2.57B-40.84%
Dec 31, 2023
6.29B2.55B+68.08%
Dec 31, 2022
3.74B2.83B+309.83%
Dec 31, 2021
913.79M-1.43B-61.08%
Dec 31, 2020
2.35B-3.88B-62.27%
Dec 31, 2019
6.22B3.71B+147.92%
Dec 31, 2018
2.51B908.91M+56.75%
Dec 31, 2017
1.60B660.06M+70.11%
Dec 31, 2016
941.50M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis